10x Genomics, Inc.

10x Genomics develops instruments, consumables, and software platforms for single-cell and spatial genomic analysis. The company's core offerings enable researchers to analyze individual biological components and preserve the spatial context of gene expression within tissue samples. Primary platforms include Chromium, which provides single-cell RNA sequencing and analysis capabilities through microfluidic technology; Visium, a spatial transcriptomics platform using high-density DNA arrays to map biological analytes within samples; and Xenium Analyzer, an in situ imaging instrument that detects hundreds of RNA targets directly in tissue sections without conventional sequencing. The company also supplies related consumables, slides, and reagents for these platforms.

Software products complement its hardware offerings, including Cell Ranger for single-cell RNA sequencing data processing, Loupe Browser for data visualization, and Xenium Explorer for spatial data analysis. These tools enable researchers to process and interpret genomic datasets generated on 10x platforms.

The company serves academic institutions, government research facilities, biopharmaceutical companies, and biotechnology firms globally. With 1,178 full-time employees and headquarters in Pleasanton, California, 10x Genomics maintains operations across North America, Europe, the Middle East, Africa, and Asia Pacific regions. The company was incorporated in Delaware in 2012 and listed on Nasdaq.